Infection diagnostic devices get a faster path to market in the US
What happened
US health regulators just made it easier to sell devices that detect infections using a specific genetic test. This means manufacturers of these diagnostic tools will face less paperwork and a faster approval process.
Why it matters
New medical devices often face a long, expensive approval process, especially if they are novel. This rule means a specific type of infection-detecting device can now get to market with fewer regulatory hurdles. This could speed up how quickly doctors can diagnose certain infections.
The signal
Watch for an increase in the number of new infection-detecting devices that receive US approval in the next two years.